Eli Lilly ( LLY 2.04%) is the most valuable healthcare company in the world, as its valuation hovers around $1 trillion. It ...

But the issue with CRISPR is that it's been a slow rollout, and its business continues to incur significant losses. Is it ...

Realty Income ( O +0.31%) and Main Street Capital ( MAIN +1.17%) have extensive track records of increasing their ...

MercadoLibre operates a leading e-commerce and fintech platform serving consumers and businesses across Latin America.

Interestingly, though, the SPDR S&P 500 has an expiration date. Set up as a unit investment trust, the entity will ...

Turning Point's pivot to white nicotine pouches is going well, but is temporarily weighing on the company's profitability.

Duolingo, Shift4, CoreWeave, or Netflix? 2 of these are down by more than 45%. Here is the one I'm buying hand over fist.

Will it be a durable AI-powered subscription platform, or a mature consumer app facing new competitive pressures?

For years, UnitedHealth Group (UNH 0.73%) stock has been a terrific growth investment. In fact, it looked unstoppable. Not only did it repeatedly grow its dividend, but the stock ...

For example, investing $100 a month into three stocks (a total of $300 each month) that are generating a 12.5% annualized total return would grow to more than $1 million in 30 years. To reach $1 ...

This clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach.

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.